# PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

> **NCT04041128** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Ovarian Cancer
- Breast Cancer

## Interventions

- **DRUG:** Lynparza

## Key facts

- **NCT ID:** NCT04041128
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-23
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04041128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04041128, "PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04041128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*